Categories
Corporate

Sensex rallies 450 points, Nifty crosses 24,150 mark

Tech Mahindra, TCS advance. Sun Pharma, IndusInd Bank lag today

The markets opened the week on a strong note on Monday as the BSE Sensex advanced about 480 points in early trade, while the Nifty50 moved above the 24,100 level, signalling renewed investor confidence.

Technology stocks spearheaded the rebound after facing selling pressure in the previous session. Tech Mahindra, TCS and Infosys witnessed robust buying, lifting the broader market. Reliance Industries also remained a key contributor to the uptrend as investors monitored developments surrounding Jio Platforms and its reported IPO plans.

Investors found reassurance in declining crude oil prices, which helped ease worries over inflation and India’s import costs. A steady rupee and expectations of continued foreign institutional investor inflows further boosted market sentiment. Analysts noted that investors were selectively adding fundamentally strong large-cap stocks, especially in the technology and energy segments.

Tech Mahindra, TCS, Reliance Industries, Infosys and HCLTech featured among the top gainers on the Sensex. Their advances outweighed losses in select banking and pharmaceutical stocks. Sun Pharma, IndusInd Bank and Kotak Mahindra Bank were among the notable laggards as some investors booked profits.

Corporate news also kept investors engaged. Sun Pharma announced the acquisition of Innovcare Lifesciences for ₹271.2 crore, while Tata Motors secured orders for over 3,400 electric commercial vehicles. Bharat Forge drew attention after bagging a ₹425-crore defence contract, strengthening interest in defence and capital goods stocks.

According to market experts, the near-term outlook remains constructive as long as global sentiment stays favourable. Lower oil prices, a stable rupee and improving foreign investor participation continue to support equities. However, investors are closely tracking geopolitical developments and upcoming signals from the US Federal Reserve, which could impact market direction.

Also Read: Deepinder Goyal’s Temple unveils new health biomarker

Leave a Reply

Your email address will not be published. Required fields are marked *